Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



GSK delivers strong 2024 performance with further improvement to long-term growth outlook

February 07, 2025
GSK PLC (GSK) reported a strong performance in 2024 with an improved outlook for long-term growth. The company's revenue exceeded expectations, thanks to the success of its HIV and cancer drugs. The positive results have led GSK to launch a 2 billion dollar share buyback program. Despite the challenges faced by the global vaccine market, GSK remains optimistic about its vaccine portfolio. Experts from Stocks Prognosis recommend considering buying GSK stocks for a favorable forecast of their movement.

Find out how the GSK PLC rate is expected to change

Get Forecast for GSK

Investor opinions & comments:

While GSK's revenue exceeded expectations, it's important to consider if this growth is sustainable. The success of their HIV and cancer drugs might not be consistent in the future
— from KatherineSanchez at 02-10-2025 10:43
I'm definitely considering buying GSK stocks based on these positive results. Their revenue exceeding expectations is a promising sign for the company
— from MoneyMabel at 02-09-2025 03:25
The 2 billion dollar share buyback program sounds like a smart move by GSK. It shows their confidence in their future performance
— from DividendDylan at 02-08-2025 17:22
GSK's optimistic outlook for their vaccine portfolio is encouraging. Vaccines play a crucial role in public health, and GSK's commitment to improving and expanding their portfolio is commendable
— from NatalieBaker at 02-08-2025 14:53
It's great to see GSK's revenue exceeding expectations. This demonstrates their strong market position and potential for future growth
— from WealthyWanda at 02-08-2025 10:06
GSK's strong performance in 2024 is impressive. Their success in the HIV and cancer drug market is a testament to their innovation and ability to meet healthcare needs
— from LoganWard at 02-07-2025 23:09
This is great news for GSK! I'm excited to see how their HIV and cancer drugs continue to perform and drive their long-term growth
— from MoneyMonique at 02-07-2025 15:55
I'm not sure if GSK can sustain this level of growth in the long term. The pharmaceutical industry is highly competitive, and it's difficult to predict how market dynamics will change
— from MarketMason at 02-07-2025 06:41
I'm skeptical about GSK's vaccine portfolio. With the challenges faced by the global vaccine market, it's uncertain how successful GSK will be in this area
— from SaraBrown at 02-07-2025 06:00
If you want to leave a comment, then you need Login or Register





Other news for GSK

GSKJune 2, 2025QuantWave Delivers 7.39% Profit with Successful GSK PLC Stock Price Target Forecast  ~2 min.

On March 21, 2025, QuantWave, the automated forecasting platform, signaled a long position for GSK PLC at a price of 38.79 $. Today, on June 2, 2025, the stock reached the predicted target price of 41....

GSKJune 2, 2025QuantWave Hits Price Target Forecast for GSK PLC, Yielding 8.78% Profit  ~1 min.

QuantWave, the automated forecasting platform, successfully achieved its price target forecast for GSK PLC, resulting in a profit of 8.78%....

GSKJune 2, 2025QuantWave Achieves GSK PLC Price Target Forecast with 6.93% Profit  ~1 min.

QuantWave, the leading automated forecasting platform, has successfully hit the price target forecast for GSK PLC, resulting in a profitable trade with a 6.93% gain....

GSKJune 2, 2025QuantWave Achieves 8.39% Profit Target Forecast for GSK PLC Stock  ~1 min.

QuantWave, an automated forecasting platform, has successfully hit a price target forecast for the stock of GSK PLC, resulting in a profit of 8.39%....

GSKJune 2, 2025QuantWave Achieves 11.28% Profit Target Forecast for GSK PLC  ~1 min.

QuantWave, the automated forecasting platform, successfully predicted a long position for GSK PLC on April 1, 2025, when the stock was trading at $37.44....



Related news

BRK-BDecember 25, 2024Is Berkshire Hathaway Inc. BRK-B the Best Stock in Bill Gates Portfolio Right Now?  ~1 min.

According to recent reports, Berkshire Hathaway Inc. BRK-B is one of the top stocks in Bill Gates' portfolio....

Sustainable Investing and Stock Market Trends in 2025  ~3 min.

As we move into the year 2025, sustainable investing continues to gain popularity among investors looking to incorporate environmental, social, and governance (ESG) considerations into their portfolios....

MAOctober 29, 2024Mastercard Incorporated Expands Portfolio of Restoration Sites: MA Stock News  ~2 min.

Mastercard Incorporated (NYSE:MA), a leading global payments technology company, has announced the expansion of its Priceless Planet Coalitions Portfolio of Restoration Sites....

ROPJanuary 24, 2025Trust Co. of Vermont Adds Roper Technologies Inc. to their Stock Portfolio  ~2 min.

Trust Co. of Vermont recently disclosed that they now own a substantial stock position in Roper Technologies Inc. (NYSE:ROP). The company has added 565,000 shares of Roper Technologies Inc....

BRK-BDecember 29, 2024Berkshire Hathaway Inc. BRK.B Reveals Its Impressive Portfolio: Don't Miss the Opportunity to Invest  ~1 min.

Berkshire Hathaway Inc. (BRK.B) has been grabbing the attention of investors lately due to its impressive portfolio....